Compare AANJANEYA LIFECARE with NEULAND LABS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs NEULAND LABS - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS NEULAND LABS DR. DATSONS LABS/
NEULAND LABS
 
P/E (TTM) x -10.9 46.7 - View Chart
P/BV x 0.2 3.5 4.6% View Chart
Dividend Yield % 0.0 0.1 -  

Financials

 DR. DATSONS LABS   NEULAND LABS
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
NEULAND LABS
Mar-20
DR. DATSONS LABS/
NEULAND LABS
5-Yr Chart
Click to enlarge
High Rs126754 16.7%   
Low Rs31247 12.5%   
Sales per share (Unadj.) Rs133.0594.5 22.4%  
Earnings per share (Unadj.) Rs0.212.6 1.2%  
Cash flow per share (Unadj.) Rs6.637.0 17.9%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs128.8553.4 23.3%  
Shares outstanding (eoy) m31.6612.83 246.8%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.60.8 69.9%   
Avg P/E ratio x516.139.6 1,302.9%  
P/CF ratio (eoy) x11.813.5 87.6%  
Price / Book Value ratio x0.60.9 67.2%  
Dividend payout %015.8 0.0%   
Avg Mkt Cap Rs m2,4776,421 38.6%   
No. of employees `000NA1.3 0.0%   
Total wages/salary Rs m561,236 4.5%   
Avg. sales/employee Rs ThNM5,949.4-  
Avg. wages/employee Rs ThNM963.8-  
Avg. net profit/employee Rs ThNM126.4-  
INCOME DATA
Net Sales Rs m4,2117,627 55.2%  
Other income Rs m7939 202.6%   
Total revenues Rs m4,2897,666 56.0%   
Gross profit Rs m5691,019 55.8%  
Depreciation Rs m204313 65.3%   
Interest Rs m430216 199.4%   
Profit before tax Rs m13529 2.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6367 1.7%   
Profit after tax Rs m5162 3.0%  
Gross profit margin %13.513.4 101.1%  
Effective tax rate %48.069.4 69.2%   
Net profit margin %0.12.1 5.4%  
BALANCE SHEET DATA
Current assets Rs m6,8525,152 133.0%   
Current liabilities Rs m6,7113,576 187.6%   
Net working cap to sales %3.320.7 16.2%  
Current ratio x1.01.4 70.9%  
Inventory Days Days161105 153.1%  
Debtors Days Days31891 350.5%  
Net fixed assets Rs m3,6733,969 92.6%   
Share capital Rs m317129 245.4%   
"Free" reserves Rs m3,7616,971 54.0%   
Net worth Rs m4,0787,100 57.4%   
Long term debt Rs m1,671774 215.9%   
Total assets Rs m12,63312,310 102.6%  
Interest coverage x1.03.5 29.8%   
Debt to equity ratio x0.40.1 376.0%  
Sales to assets ratio x0.30.6 53.8%   
Return on assets %3.43.1 112.2%  
Return on equity %0.12.3 5.2%  
Return on capital %7.79.5 81.1%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m9645,187 18.6%   
Fx outflow Rs m6071,593 38.1%   
Net fx Rs m3573,594 9.9%   
CASH FLOW
From Operations Rs m1,345573 234.5%  
From Investments Rs m-2,256-487 463.4%  
From Financial Activity Rs m-1,200-55 2,189.4%  
Net Cashflow Rs m-2,11133 -6,474.5%  

Share Holding

Indian Promoters % 4.5 36.3 12.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 63.7 -  
FIIs % 1.4 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 63.7 147.7%  
Shareholders   20,807 12,705 163.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   NATCO PHARMA  FRESENIUS KABI ONCO.  FDC  ABBOTT INDIA  STRIDES PHARMA SCIENCE  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

A Time Correction in the Nifty(Momentum Moves)

The week belonged to the bulls after bears ended the party in February. March started with gains for the bulls but historically, March has been a bears' month.

Related Views on News

NEULAND LABS Announces Quarterly Results (3QFY21); Net Profit Up 141.5% (Quarterly Result Update)

Feb 3, 2021 | Updated on Feb 3, 2021

For the quarter ended December 2020, NEULAND LABS has posted a net profit of Rs 267 m (up 141.5% YoY). Sales on the other hand came in at Rs 2 bn (up 20.5% YoY). Read on for a complete analysis of NEULAND LABS's quarterly results.

NEULAND LABS 2019-20 Annual Report Analysis (Annual Result Update)

Sep 2, 2020 | Updated on Sep 2, 2020

Here's an analysis of the annual report of NEULAND LABS for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of NEULAND LABS. Also includes updates on the valuation of NEULAND LABS.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS